Janet Dancey

Program Leader, High Impact Clinical Trials

Research Description

Dr. Janet Dancey is the leader of the High Impact Clinical Trials program at OICR and the Director of Clinical Translational Research at the NCIC Clinical Trials Group. The High Impact Clinical Trials program will facilitate the translation of discoveries from laboratory to clinic by providing infrastructure and resources to support trials evaluating markers for early diagnosis, prognosis, and predication of benefit to help develop better treatments for cancer patients.

Contact Information

Telephone
+1 (416) 673 6532
Email
janet.dancey@oicr.on.ca
Mailing Address
Ontario Institute for Cancer Research
MaRS Centre, South Tower
101 College Street, Suite 800
Toronto, Ontario
Canada, M5G 0A3
NCIC Clinical Trials Group
Queen’s University
10 Stuart St
Kingston, Ontario
Canada, K7L 3N6

Current

2008 - Professor, Department of Oncology, Queen's University.
2008 - Director, Clinical Translational Research, NCIC Clinical Trials Group.
2008 - Program Leader, High Impact Clinical Trials, Ontario Institute for Cancer Research (OICR).
2008 - Chair, Experimental Therapeutics Network, Cancer Care Ontario (CCO).

Background

2007 - 2008Associate Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute.
1999 - 2007Senior Clinical Investigator, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute.
1997 - 1999Assistant Professor, Faculty of Medicine, University of Toronto.
1996 - 1999Active Staff, Department of Medicine, Division of Hematology/Oncology, The Toronto Hospital/Ontario Cancer Institute/ Princess Margaret Hospital.
1995Clinical Research Fellow, Institut Gustave Roussy. Supervisor: Dr Thierry Le Chevalier.
1994 - 1997Lecturer, Faculty of Medicine, University of Toronto.
1994 - 1995Clinical Research Fellow, NCIC Clinical Trials Group. Supervisors: Dr. Joseph L. Pater and Dr. Elizabeth Eisenhauer.
1994 - 1995Consultant, Kingston Regional Cancer Clinic.
1993 - 1994Medical Oncologist, St. Michael's Hospital, Department of Medicine.
1993FRCPC Certification in Medical Oncology, .
1988MD, Magna Cum Laude, University of Ottawa.

Selected Bibliography

  • Dancey J. Early Clinical Trial Design Issues: Patient Populations, Endpoints and Barriers. In: Pandya KJ, Brahmer J, Hidalgo M, editors. Lung Cancer: Translational and Emerging Therapies. New York: Taylor & Francis Group, LLC; 2007.
    • Dancey J and Chen H. Strategies for optimizing combinations of molecularly targeted anticancer agents. Nature Reviews Drug Discovery. 5:649-59; 2006.
      • Dancey JE. Predictive Factors for Epidermal Growth Factor Receptor Inhibitors – The Bull’s-Eye Hits the Arrow. Cancer Cell. 5:411-5; 2004.
        • Dancey J and Sausville E. Issues And Progress With Protein Kinase Inhibitors For Cancer Treatment. Nat Rev Drug Discov. 2:296-313; 2003.
          • Dancey J, Freidlin B. Agents Targeting EGFR: Are We Missing the Mark? Lancet. 362:62-4; 2003.